The recent US patent for TrialAssure's date offset technology reveals a deeper struggle over clinical trial data integrity and ownership.
The FDA's Digital Health COE isn't just about innovation; it's a quiet power play shaping the future of digital health regulation.
The FDA's new TEMPO digital health pilot signals a massive shift in medical device oversight. Who really benefits from this accelerated regulatory path?
The retraction of a Monsanto Roundup safety study due to 'serious ethical concerns' signals a crisis far deeper than just one paper.
The retraction of a landmark glyphosate study exposes a terrifying truth about scientific integrity and corporate influence in health reporting.
The FDA's new digital health services pilot, lauded by the AHA, signals a massive shift in medical liability. Discover who really benefits from this regulatory experiment.